| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 15 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.66M | - | |
| CFO | 58.4K | $16.73M | - | |
| VP | 29.8K | $8.52M | - | |
| VP | 23.7K | $6.78M | - | |
| Dir | 23.2K | $6.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2017 | Vaishnaw Akshay56 | EVP, R&D | Sale+OE | 33,666 | $121.46 | $4,088,967.46 | -24.4% | |
| Oct 2, 2017 | Greene Barry E | President | Sale+OE | 85,316 | $125.00 | $10,664,500.00 | -45.9% | |
| Sep 20, 2017 | Greene Barry E | President | Sale+OE | 76,815 | $100.00 | $7,681,500.00 | -46.4% | |
| May 30, 2017 | Keating Laurie55 | SVP, GC And Secretary | Buy | 11,500 | $65.35 | $751,502.00 | New | |
| May 23, 2017 | Vaishnaw Akshay56 | EVP, R&D | Sale+OE | 11,000 | $75.00 | $825,000.00 | -51.7% | |
| May 16, 2017 | Mason Michael88 | VP, Finance And Treasurer | Sale+OE | 9,375 | $70.00 | $656,250.00 | -100% | |
| May 15, 2017 | Vaishnaw Akshay56 | SVP, R&D | Sale+OE | 43,750 | $65.00 | $2,843,750.00 | -68.0% | |
| Feb 1, 2017 | Sharp Philip A45 | Director | Sale+OE | 25,000 | $39.80 | $995,124.76 | -8.0% | |
| Jan 25, 2017 | Sharp Philip A45 | Director | Sale+OE | 15,000 | $37.95 | $569,250.00 | -9.6% | |
| Jan 18, 2017 | Sharp Philip A45 | Director | Sale+OE | 15,000 | $37.83 | $567,456.00 | -5.0% |